Literature DB >> 25999248

IL-7: AhR We Ready for a New Cytokine to Fight Colitis?

Atsuhito Nakao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25999248     DOI： 10.1007/s10620-015-3721-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

1.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

2.  Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice.

Authors:  Takeyuki Takamura; Daisuke Harama; Shuji Matsuoka; Naomi Shimokawa; Yuki Nakamura; Ko Okumura; Hideoki Ogawa; Masanori Kitamura; Atsuhito Nakao
Journal:  Immunol Cell Biol       Date:  2010-03-16       Impact factor: 5.126

Review 3.  Homeostatic maintenance of T cells and natural killer cells.

Authors:  Onur Boyman; Carsten Krieg; Dirk Homann; Jonathan Sprent
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

4.  Aryl Hydrocarbon Receptor Activation Down-Regulates IL-7 and Reduces Inflammation in a Mouse Model of DSS-Induced Colitis.

Authors:  Tao Ji; Chao Xu; Lihua Sun; Min Yu; Ke Peng; Yuan Qiu; Weidong Xiao; Hua Yang
Journal:  Dig Dis Sci       Date:  2015-03-24       Impact factor: 3.199

5.  Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation.

Authors:  Ying Li; Silvia Innocentin; David R Withers; Natalie A Roberts; Alec R Gallagher; Elena F Grigorieva; Christoph Wilhelm; Marc Veldhoen
Journal:  Cell       Date:  2011-10-13       Impact factor: 41.582

6.  The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells.

Authors:  Ju Qiu; Jennifer J Heller; Xiaohuan Guo; Zong-ming E Chen; Kamonwan Fish; Yang-Xin Fu; Liang Zhou
Journal:  Immunity       Date:  2011-12-15       Impact factor: 31.745

Review 7.  Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.

Authors:  Takanori Kanai; Yasuhiro Nemoto; Nobuhiko Kamada; Teruji Totsuka; Tadakazu Hisamatsu; Mamoru Watanabe; Toshifumi Hibi
Journal:  Curr Opin Gastroenterol       Date:  2009-07       Impact factor: 3.287

Review 8.  The aryl hydrocarbon receptor in immunity.

Authors:  Charlotte Esser; Agneta Rannug; Brigitta Stockinger
Journal:  Trends Immunol       Date:  2009-08-21       Impact factor: 16.687

9.  Specific overexpression of IL-7 in the intestinal mucosa: the role in intestinal intraepithelial lymphocyte development.

Authors:  Hua Yang; Blair Madison; Deborah L Gumucio; Daniel H Teitelbaum
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-10       Impact factor: 4.052

Review 10.  The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein.

Authors:  Robert Barouki; Xavier Coumoul; Pedro M Fernandez-Salguero
Journal:  FEBS Lett       Date:  2007-03-30       Impact factor: 4.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.